Lansoprazole vs Rituximab
Lansoprazole vs Rituximab: Overview
This comparison examines the pharmacological differences between Lansoprazole and Rituximab.
Mechanism of Action
Lansoprazole: Proton pump inhibitor.
Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.
Pharmacokinetics
Half-life: Lansoprazole — 1.5 hours; Rituximab — 22 days.
Chemical Properties
Molecular Formula: Lansoprazole — C16H14F3N3O2S.
Molecular Weight: Lansoprazole — 369.3620 g/mol.
Type: Lansoprazole — Small molecule; Rituximab — Antibody.